These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27020471)

  • 1. Recent Advances in chemistry and pharmacology of 2-methoxyestradiol: An anticancer investigational drug.
    Kumar BS; Raghuvanshi DS; Hasanain M; Alam S; Sarkar J; Mitra K; Khan F; Negi AS
    Steroids; 2016 Jun; 110():9-34. PubMed ID: 27020471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic 2-methoxyestradiol derivatives: structure-activity relationships.
    Peyrat JF; Brion JD; Alami M
    Curr Med Chem; 2012; 19(24):4142-56. PubMed ID: 22709003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure activity analysis of 2-methoxyestradiol analogues reveals targeting of microtubules as the major mechanism of antiproliferative and proapoptotic activity.
    Chua YS; Chua YL; Hagen T
    Mol Cancer Ther; 2010 Jan; 9(1):224-35. PubMed ID: 20053769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease.
    Parada-Bustamante A; Valencia C; Reuquen P; Diaz P; Rincion-Rodriguez R; Orihuela PA
    Mini Rev Med Chem; 2015; 15(5):427-38. PubMed ID: 25723461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of 2-methoxyestradiol: new developments.
    Mooberry SL
    Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of a computer-designed potential anticancer agent in cervical cancer cells.
    Visagie MH; Jaiswal SR; Joubert AM
    Biol Res; 2016 Nov; 49(1):43. PubMed ID: 27806731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent.
    Mooberry SL
    Curr Opin Oncol; 2003 Nov; 15(6):425-30. PubMed ID: 14624224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol.
    Hagen T; D'Amico G; Quintero M; Palacios-Callender M; Hollis V; Lam F; Moncada S
    Biochem Biophys Res Commun; 2004 Sep; 322(3):923-9. PubMed ID: 15336552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
    Verenich S; Gerk PM
    Mol Pharm; 2010 Dec; 7(6):2030-9. PubMed ID: 20831190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol.
    Lakhani NJ; Sparreboom A; Xu X; Veenstra TD; Venitz J; Dahut WL; Figg WD
    J Pharm Sci; 2007 Jul; 96(7):1821-31. PubMed ID: 17252610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol.
    Lakhani N; Sparreboom A; Venitz J; Dahut WL; Figg WD
    Anticancer Drugs; 2006 Sep; 17(8):977-83. PubMed ID: 16940808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.
    Sathish Kumar B; Kumar A; Singh J; Hasanain M; Singh A; Fatima K; Yadav DK; Shukla V; Luqman S; Khan F; Chanda D; Sarkar J; Konwar R; Dwivedi A; Negi AS
    Eur J Med Chem; 2014 Oct; 86():740-51. PubMed ID: 25238172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor.
    Gorska-Ponikowska M; Perricone U; Kuban-Jankowska A; Lo Bosco G; Barone G
    J Cell Physiol; 2017 Nov; 232(11):3030-3049. PubMed ID: 28262924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAR studies of 2-methoxyestradiol and development of its analogs as probes of anti-tumor mechanisms.
    Ho A; Kim YE; Lee H; Cyrus K; Baek SH; Kim KB
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3383-7. PubMed ID: 16650989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.
    Sutherland TE; Anderson RL; Hughes RA; Altmann E; Schuliga M; Ziogas J; Stewart AG
    Drug Discov Today; 2007 Jul; 12(13-14):577-84. PubMed ID: 17631253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antitubulin, and antiproliferative SAR of analogues of 2-methoxyestradiol-3,17-O,O-bis-sulfamate.
    Jourdan F; Leese MP; Dohle W; Hamel E; Ferrandis E; Newman SP; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2010 Apr; 53(7):2942-51. PubMed ID: 20225862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short, economical synthesis of 2-methoxyestradiol, an anticancer agent in clinical trials.
    Hou Y; Meyers CY; Akomeah M
    J Org Chem; 2009 Aug; 74(16):6362-4. PubMed ID: 19610601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors.
    Schumacher G; Neuhaus P
    J Cancer Res Clin Oncol; 2001 Jul; 127(7):405-10. PubMed ID: 11469676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of 2-methoxyestradiol in the hepatocellular carcinoma cell line HepG2.
    El Naga RN; El-Demerdash E; Youssef SS; Abdel-Naim AB; El-Merzabani M
    Pharmacology; 2009; 84(1):9-16. PubMed ID: 19478548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
    Sudhakar G; Bathula SR; Banerjee R
    Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.